Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danqing Xu

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Kidney & Blood Pressure Research|February 8, 2018
The Association of Weekly pre-Hemodialysis Systolic Blood Pressure and Following Week MortalityDugan Maddux, Len A Usvyat, Danqing Xu, et al.
Clinics and Research in Hepatology and Gastroenterology|May 5, 2024
Factors influencing pathological changes in the liver tissue in hepatitis B virus carriers with low-level viremiaHaiyan Fu, Hongjuan Li, Yingrong Du, et al.
Investigational New Drugs|March 31, 2010
5k, a novel β-O-demethyl-epipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosisDanqing Xu, Ji Cao, Shijing Qian, et al.
Analytical Chemistry|October 28, 2025
Bifunctional Fluorescent Probe for Simultaneous Imaging of H<sub>2</sub>S and Hcy Crosstalk and Therapeutic Evaluation in Acute Kidney InjuryTing Yu, Zhengze Long, Yang Li, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|October 12, 2025
Triple-Channel fluorescent probe for simultaneous detection of Cys, SO₂, and H₂S to discriminate Cancer cells via Transsulfuration pathway metabolic profilingXin Jiang, Bo Liu, Yang Li, et al.
Frontiers in Pharmacology|January 4, 2021
The Natural Compound Oblongifolin C Exhibits Anticancer Activity by Inhibiting HSPA8 and Cathepsin B <i>In Vitro</i>Li Han, Danqing Xu, Zhichao Xi, et al.
Plos One|June 12, 2013
Small molecule R1498 as a well-tolerated and orally active kinase inhibitor for hepatocellular carcinoma and gastric cancer treatment via targeting angiogenesis and mitosis pathwaysChao Zhang, Xihan Wu, Meifang Zhang, et al.
Ebiomedicine|October 24, 2018
Screening of FDA-approved drugs identifies sutent as a modulator of UCP1 expression in brown adipose tissueYan Qiu, Yingmin Sun, Danqing Xu, et al.
NPJ Digital Medicine|July 24, 2021
Quantitative disease risk scores from EHR with applications to clinical risk stratification and genetic studiesDanqing Xu, Chen Wang, Atlas Khan, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 20, 2016
Identification of New ATG4B Inhibitors Based on a Novel High-Throughput Screening PlatformDanqing Xu, Zhiheng Xu, Li Han, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Kidney & Blood Pressure Research|February 8, 2018
The Association of Weekly pre-Hemodialysis Systolic Blood Pressure and Following Week MortalityDugan Maddux, Len A Usvyat, Danqing Xu, et al.
Clinics and Research in Hepatology and Gastroenterology|May 5, 2024
Factors influencing pathological changes in the liver tissue in hepatitis B virus carriers with low-level viremiaHaiyan Fu, Hongjuan Li, Yingrong Du, et al.
Investigational New Drugs|March 31, 2010
5k, a novel β-O-demethyl-epipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosisDanqing Xu, Ji Cao, Shijing Qian, et al.
Analytical Chemistry|October 28, 2025
Bifunctional Fluorescent Probe for Simultaneous Imaging of H<sub>2</sub>S and Hcy Crosstalk and Therapeutic Evaluation in Acute Kidney InjuryTing Yu, Zhengze Long, Yang Li, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|October 12, 2025
Triple-Channel fluorescent probe for simultaneous detection of Cys, SO₂, and H₂S to discriminate Cancer cells via Transsulfuration pathway metabolic profilingXin Jiang, Bo Liu, Yang Li, et al.
Frontiers in Pharmacology|January 4, 2021
The Natural Compound Oblongifolin C Exhibits Anticancer Activity by Inhibiting HSPA8 and Cathepsin B <i>In Vitro</i>Li Han, Danqing Xu, Zhichao Xi, et al.
Plos One|June 12, 2013
Small molecule R1498 as a well-tolerated and orally active kinase inhibitor for hepatocellular carcinoma and gastric cancer treatment via targeting angiogenesis and mitosis pathwaysChao Zhang, Xihan Wu, Meifang Zhang, et al.
Ebiomedicine|October 24, 2018
Screening of FDA-approved drugs identifies sutent as a modulator of UCP1 expression in brown adipose tissueYan Qiu, Yingmin Sun, Danqing Xu, et al.
NPJ Digital Medicine|July 24, 2021
Quantitative disease risk scores from EHR with applications to clinical risk stratification and genetic studiesDanqing Xu, Chen Wang, Atlas Khan, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 20, 2016
Identification of New ATG4B Inhibitors Based on a Novel High-Throughput Screening PlatformDanqing Xu, Zhiheng Xu, Li Han, et al.
Pageof 3